Tag: Pharmacovigilance

Candis Edwards: Guiding Innovation, Elevating Compliance, Advancing Global Health

I am excited to share a deeper look into my professional journey and the experiences that have shaped my passion for regulatory leadership, pharmaceutical innovation, and organizational integrity. Throughout my 45-year career, I have had the privilege of contributing to companies, teams, and missions that advance global health and patient safety. Here is my biography.

Marianne Savage: Transformational Technology Leader Driving Innovation in Life Sciences and Regulated Industries

Marianne Savage is a seasoned technology executive and life sciences strategist with a distinguished career leading enterprise innovation across regulated industries. With over 40 years of experience spanning global product management, pharmacovigilance, and go-to-market strategy, she has played a pivotal role in transforming legacy systems into modern, cloud-based platforms that meet stringent compliance standards. Marianne’s ability to blend deep regulatory knowledge with technical fluency and operational leadership has earned her a reputation as a trusted advisor, team builder, and driver of strategic growth.

Nina Patel Lahanis: Senior Executive in Life Sciences, Business Development, and Operations Leadership

Nina Patel Lahanis is a senior executive with over 30 years of experience in the biopharma industry, specializing in pharmacovigilance, regulatory affairs, and operational management. Currently serving as Vice President at PrimeVigilance, Nina leads strategic initiatives to ensure compliance across the Americas, optimizing resources and driving technological innovation. Throughout her career, she has excelled in business development, client relationship management, and cross-functional leadership, with a proven track record of driving revenue growth and operational efficiencies. Nina’s global experience spans multiple regions, including India, Canada, and the UK, and her multilingual skills enable her to build strong, diverse relationships. She is deeply committed to advancing regulatory safety and compliance and is eager to lend her expertise to boards and advisory roles in the biopharma and life sciences sectors.